Genes & Diseases-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2025-03-24 ms2000000379357303 来自澳门

DIP15天了

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2025-04-14 ms1000001241616711 来自江苏省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;耐药
经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2023-09-18 小中医7519 来自天津

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：癌症;表观遗传;耐药
经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇

583 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2024-12-01 ms7000001215694189 来自上海

太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。

48 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2025-02-13 ms1000001305582775 来自湖南省

1月20号投稿，21号改格式，2月13号都还没稿号，真麻了

35 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2025-02-21 Anghuhao 来自湖南省

1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。

17 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2025-01-07 1232295cm61暂无昵称来自重庆

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id

33 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2024-12-19 ms3000001788822144 来自上海

审稿速度:6.0
偏重的研究方向：医学
经验分享：5月5日投稿
6月1日送交编辑
6月15日送审中
9月25日决定进行中
12月15日要求改投为短篇通讯。
知道慢，没想到这么慢，谁能想到同行评审流程需要6个月

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2024-12-18 1811fd99f7m 来自佛罗里达

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：乳腺癌
经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2257539, encodeId=6e06225e53986, content=DIP15天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4048394508, createdName=ms2000000379357303, createdTime=Mon Mar 24 19:13:32 CST 2025, time=2025-03-24, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2260417, encodeId=a6ea226041ee9, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;耐药 经验分享：总体偏慢，2024.7.7投稿，要求改成 Rapid Communication，7.30投出，三天后under review，24.11.18两位审稿人给小修，主要是改文字和讨论上的一些东西，给的建议还是挺中肯的。24.11.30返回，with eitor过了2个月没消息，后来2025.2.13发邮件催了下，第二天变成under review，3.4 required review completed，等了一个月，4.13变成dip，4.14接收。还好不是毕业用，看预测今年会涨分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82f38610878, createdName=ms1000001241616711, createdTime=Mon Apr 14 14:49:28 CST 2025, time=2025-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：癌症;表观遗传;耐药 经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=583, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240270, encodeId=8ec222402e0c2, content=太慢了，说好的第一决定16天，这年头没一个是诚实的说真话的。我这with editor快一个月了，从投稿到现在一个多月了，照样没动静，着急毕业呀。投个文章真要命。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Sun Dec 01 19:23:10 CST 2024, time=2024-12-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251827, encodeId=ecc1225182e87, content=1月20号投稿，21号改格式，2月13号都还没稿号，真麻了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=946b5683908, createdName=ms1000001305582775, createdTime=Thu Feb 13 22:32:31 CST 2025, time=2025-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2252987, encodeId=8709225298e72, content=1.4投，1.6改格式，1.19给了稿号，1.20under review，1.23under review，2.20under review，更新under review啥意思啊。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Fri Feb 21 15:47:15 CST 2025, time=2025-02-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2246906, encodeId=3d592246906a1, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：元旦投稿，中间改了一次格式1.3.目前1.7还是STJ。有点慢啊，多久才能有id, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Tue Jan 07 09:40:20 CST 2025, time=2025-01-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2243419, encodeId=d8c92243419fa, content=审稿速度:6.0 偏重的研究方向：医学 经验分享：5月5日投稿 6月1日送交编辑 6月15日送审中 9月25日决定进行中 12月15日要求改投为短篇通讯。 知道慢，没想到这么慢，谁能想到同行评审流程需要6个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Thu Dec 19 00:02:44 CST 2024, time=2024-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243238, encodeId=f577224323843, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：刚投一篇，12月12日投稿，13日要求改格式，之后到现在一直显示sub to journal，至今没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1d432135091, createdName=1811fd99f7m, createdTime=Wed Dec 18 10:27:51 CST 2024, time=2024-12-18, status=1, ipAttribution=佛罗里达), GetPortalCommentsPageByObjectIdResponse(id=2149800, encodeId=0ab12149800f3, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea5b1580962, createdName=caihua1204, createdTime=Tue Jul 25 20:33:01 CST 2023, time=2023-07-25, status=1, ipAttribution=江西省)]

2023-07-25 caihua1204 来自江西省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：5.6提交，然后10天后改格式，然后6.16日返回修改意见，6.26日修回，7月24日接受，时间约2个月

401 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务